Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients

Ashfaq, Muhammad; Khan, Qasim; Haroon, Muhammad Zeeshan; Abid, Syed Mobasher Ali; Sharif, Muhammad Junaid Hassan; Alkahraman, Yasser M. S. A.

doi:10.1007/s12020-023-03572-8

Endocrine

2023

DOI: 10.1007/s12020-023-03572-8

|View full text |Cite

Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients

Muhammad Ashfaq,

Qasim Khan,

Muhammad Zeeshan Haroon

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Prevalence of Hyperprolactinemia in Patients Undergoing Long-Term Proton Pump Inhibitor Therapy

Zubair,

Amil,

Noureen

et al. 2024

PJHS-Lahore

View full text Add to dashboard Cite

Proton pump inhibitors used to treat gastrointestinal disorders cause various threatening effects and lead to an increase in serum prolactin levels. Objectives: To evaluate serum prolactin and macroprolactin levels in long-term proton pump inhibitor therapy patients. Method: An observational cross-sectional study was done between February 2023 and June 2024, at Niazi Welfare Foundation Teaching Hospital, Sargodha after approval from the institutional review board. Patients of either gender using proton pump inhibitors for ≥3 months, alone or in combination with histamine 2 receptor antagonists or pro-kinetics were included to measure serum prolactin levels. A duration of >3 months was taken as long-term therapy to see the impact on prolactin levels. The data were analyzed using SPSS version 25.0. Results: Out of the 166 patients, 102 (61.4%) were female, and 64 (38.6%) were male. The patient's mean age was 42.6 ± 14.3 years, and serum prolactin level was 23.2ng/mL. Among the participants, 97 (58.4%) had normoprolactinemia, while 69 (41.6%) had hyperprolactinemia. A significant increase in hyperprolactinemia with longer proton pump inhibitor treatment duration was revealed. Conclusions: It was concluded that prolonged use of proton pump inhibitors has the potential to raise serum prolactin levels, highlighting the importance of thorough evaluation for optimal clinical management.

show abstract

Prevalence of Hyperprolactinemia in Patients Undergoing Long-Term Proton Pump Inhibitor Therapy

Zubair,

Amil,

Noureen

et al. 2024

PJHS-Lahore

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effects of long-term proton pump inhibitor use on sexual hormones and sexual and reproductive health in female patients

Cited by 1 publication

References 34 publications

Prevalence of Hyperprolactinemia in Patients Undergoing Long-Term Proton Pump Inhibitor Therapy

Prevalence of Hyperprolactinemia in Patients Undergoing Long-Term Proton Pump Inhibitor Therapy

Contact Info

Product

Resources

About